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Objective: To examine whether sepsis is accurately coded
on hospital bills. 
Methods: Hospital inpatient uniform bills (UB-92) for
122 patients with clinically documented severe sepsis of
presumed infectious origin were retrospectively exam-
ined. Final UB-92 hospital bills were obtained for all
study subjects. ICD-9-CM diagnosis codes from these
bills were then reviewed to ascertain the number of sub-
jects for whom one or more diagnostic codes for sep-
ticemia and/or bacteremia were present.
Results: A total of 92 hospital bills (75.4%) contained
one or more ICD-9-CM diagnostic codes for septicemia
and/or bacteremia. Of the 30 that did not, 15 (12.3%)
had codes for major systemic infection and organ failure.
No diagnoses indicative of sepsis (i.e., organ failure and
major infection) were present on the remaining 15
(12.3%) bills.
Conclusions: Our ﬁndings suggest that use of ICD-9-CM
codes for identifying patients with sepsis using hospital
bills is only moderately sensitive. Strict reliance on admin-
istrative data sources for sepsis surveillance or research
planning may therefore be prone to substantial error.
Keywords: database management systems, epidemiology,
septicemia. 
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ABSTRACT
Introduction
Sepsis is a pervasive and costly disease among hos-
pitalized patients in the United States. It is a major
cause of death among the elderly and the leading
cause of death among patients in noncoronary
intensive care units (ICUs) [1]. Estimates of the inci-
dence of sepsis vary widely, ranging from 10 to 175
per 1000 hospital admissions [2–5]. Comparisons
of incidence estimates from observational studies
are made difﬁcult by differences in study design,
entry criteria, and research settings. The most fre-
quently cited incidence estimates in the United
States are derived from administrative datasets
[6,7].
Administrative datasets are increasingly being
used for a variety of purposes, including disease 
surveillance, postmarketing evaluation of new phar-
maceuticals, and assessment of clinician perfor-
mance. While these datasets are readily accessible
and relatively inexpensive, diagnostic information
contained therein is known to be less than com-
pletely accurate. For example, the sensitivity of
coded diagnoses from health-care claims data has
been reported to be below 80% overall, ranging
from 58% for peripheral vascular disease to over
90% for several types of cancer [8,9]. Sensitivity 
for selected complications of diabetes alone 
ranges from 73% to 95% [10]. Reliance solely on
administrative data for the above-mentioned pur-
poses may therefore be subject to substantial 
misclassiﬁcation.
To explore whether coding accuracy is an issue
in sepsis, we undertook an examination of hospital
bills among patients with clinically documented
disease, using a convenience sample from a clinical
trial for severe sepsis.
Methods
We reviewed the ICD-9-CM diagnosis codes on the
hospital bills of patients with clinically documented
severe sepsis of presumed infectious origin to ascer-
tain the frequency with which codes for septicemia
and/or bacteremia were present. The study sample
consisted of 122 hospitalized patients from 10
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medical centers who were participating in a clinical
trial for severe sepsis of presumed infectious origin.
In this trial, severe sepsis was deﬁned by the
simultaneous presence of ﬁve clinical criteria, as
follows:
1. isolated organism(s) from one or more positive
cultures within 72 hours of study entry or clin-
ical diagnosis of an organ abscess or suppura-
tive inﬂammation;
2. hyperthermia (core temperature ≥38.0°C) or
hypothermia (£35.6°C);
3. tachycardia (≥90 beats/min) in the absence of
beta blockade or cardiac pacemaker;
4. tachypnea (≥20 breaths/min) or mechanical
ventilation;
5. hypotension (systolic blood pressure
£90 mmHg, decrease in systolic blood pressure
of ≥40 mmHg, or use of vasopressors), evidence
of systemic toxicity, or poor end organ perfu-
sion.
These criteria are similar to those proposed for
distinguishing severe sepsis from sepsis and systemic
inﬂammatory response syndrome (SIRS) by a 
consensus conference of the American College of
Chest Physicians and the Society for Critical Care
Medicine [11].
A ﬁnal hospital bill, in uniform bill (UB-92)
format, was also obtained for each patient in the
sample; informed consent for ﬁnancial information
was obtained for each study subject prior to enroll-
ment in the trial. Up to nine diagnoses (in ICD-
9-CM format) were included on each bill. These
diagnoses were then reviewed to determine the fre-
quency with which septicemia and/or bacteremia
was coded in the study sample. Diagnosis codes of
interest are presented in Table 1; codes for preg-
nancy-related or neonatal sepsis were excluded to
match the proﬁle of patients participating in the
trial.
Results
Of the 122 UB-92 hospital bills in the study sample,
92 (75.4%) contained one or more ICD-9-CM
codes for septicemia and/or bacteremia. The dis-
tribution of these codes is presented in Table 2.
Among the remaining 30 bills, 15 (12.3%) included
codes for major systemic infection (e.g., dissemi-
nated candidiasis) and organ failure (e.g., acidosis,
acute renal failure, secondary thrombocytopenia).
Codes for respiratory infection were most common
in this group (7/15 = 46.7%); codes for respiratory
and/or renal failure were present on all 15 of these
bills. Fifteen bills had neither codes for sepsis nor
codes for major infection and organ failure. Four 
of these had codes for major infection only, while
nine had codes for organ failure only. Two bills did
not have any codes that indicated the presence of
sepsis.
Discussion
To ascertain whether sepsis is accurately coded on
the hospital bills of patients with clinically docu-
mented disease, we examined ICD-9-CM diagnosis
codes on the UB-92 bills of 122 patients with severe
sepsis who were participating in a clinical trial.
Our ﬁndings indicate that use of ICD-9-CM
codes for identifying patients with sepsis is only
moderately sensitive and may miss up to one-
quarter of patients with this disease. Clearly, the
clinical deﬁnition of severe sepsis (evidence of sys-
temic inﬂammatory response, major infection, and
organ failure [11]) has progressed beyond what can
Table 1 Diagnosis codes for sepsis
ICD-9-CM Code Description
038.3 Anaerobic septicemia
022.3 Anthrax septicemia
790.7 Bacteremia NOS
038.42 E. coli septicemia
038.49 Gram-negative septicemia NEC
038.40 Gram-negative septicemia NOS
038.41 H. inﬂuenzae septicemia
054.5 Herpetic septicemia
036.2 Meningococcemia
038.2 Pneumococcal septicemia
038.43 Pseudomonas septicemia
003.1 Salmonella septicemia
038.8 Septicemia NEC
038.9 Septicemia NOS
020.2 Septicemic plague
038.44 Serratia septicemia
038.1 Staphylococcal septicemia
038.0 Streptococcal septicemia
Abbreviations: NEC, not elsewhere classiﬁed; NOS: not otherwise speciﬁed.
Table 2 Distribution of sepsis diagnoses among patients
with one or more sepsis codes (N = 92)
ICD-9-CM Code Description n (%)
038.1 Staphylococcal septicemia 32 (34.8)
038.9 Septicemia NOS 19 (20.7)
038.0 Streptococcal septicemia 13 (14.1)
038.2 Pneumococcal septicemia 9 (9.8)
038.49 Gram-negative septicemia NEC 8 (8.7)
038.42 E. coli septicemia 7 (7.6)
038.8 Septicemia NEC 5 (5.4)
— Other 9 (9.8)
Note: More than one sepsis code could appear on each bill; percentages may
not sum to 100.
Abbreviations: NEC, not elsewhere classiﬁed; NOS: not otherwise speciﬁed.
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be captured in a single diagnosis of septicemia or
bacteremia. However, even after we included com-
binations of ICD-9-CM diagnosis codes that would
likely indicate sepsis, over 10% of patients had
codes that provided no evidence that sepsis was
present.
The following important limitations of our
analysis should be noted. First, complete study of
the accuracy of disease classiﬁcation methods
requires ascertainment of their sensitivity and speci-
ﬁcity. Calculation of the latter was not possible in
our study because the study sample included only
patients with clinically conﬁrmed severe sepsis;
accordingly, a false-positive rate could not be cal-
culated. While our expansion of the ICD-9-CM-
based deﬁnition resulted in improved sensitivity, its
effect on speciﬁcity was unknown.
In addition, hospital information systems typi-
cally include 15 to 20 diagnosis codes for each
admission, while the UB-92 format allows for only
9 codes. It is therefore possible that, for some
patients, sepsis was coded on the medical record 
but not on the hospital bill. We believe that this
accounts for a relatively small percentage of cases,
however, because sepsis is considered a modifying
diagnosis (i.e., one that may increase payment
under Medicare’s Prospective Payment System) and
is therefore likely to appear on most hospital bills.
Conclusions
Strict reliance on administrative data sources for
sepsis surveillance or research planning may be
prone to substantial error. Health-service re-
searchers should therefore exercise caution when
employing estimates of disease incidence that are
based on administrative data. Steps should also be
taken to ensure that current standards for deﬁning
sepsis are adhered to and that coding practices are
revised accordingly.
Financial support for this study was provided by Knoll
Pharmaceutical Company, Mount Olive, New Jersey.
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